Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
The Department of Health in Northern Ireland pledge to replace the bowel cancer screening test in the country with the new, more accurate Faecal Immunochemical Test (FIT) from early 2020.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group gives an overall perspective on the challenges and concerns around acute promyelocytic leukaemia (APL), a type of blood cancer.
Dr Takashi Nakamura from Hokkaido University challenges the potential of nano-tech based drug delivery system (Nano DDS) in the development of next-generation cancer immunotherapy.
The European Elections 2019 Manifesto for the Paediatric Oncology & Haematology community has been launched, and it prioritises beating childhood cancer to aim for zero deaths.
The work of the Japanese Cancer Association in driving forward cancer research through collaboration is charted here, including a push on basic and translational research.
European Association for Cancer Research’s Chief Executive Officer, Jane Smith, explains why the advancement of cancer research is purely for the public benefit, as well as the importance of collaboration in the field.
A group of seasoned experts from the International Society for Biological and Environmental Repositories explain the notion of employing “living biobanks” to advance the field of biomedical research.
Thomas Daubon, Clotilde Billottet and Andreas Bikfalvi at the Angiogenesis and Tumor Microenvironment-INSERM U1029, Université Bordeaux provide insights into the mechanisms of primary brain tumour invasion.
Chris Wakefield, Vice President, European Marketing & Product Development, at GOJO Industries-Europe Ltd explores hand hygiene and how infection prevention measures can be strengthened to help save lives.
Scientists have discovered a critical masterswitch in the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
